Michael J. Alkire, the President & CEO of Premier, Inc. ($PINC), sold 2,100 shares of the company on 10-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4% of their shares. Following this trade, they now own 538,143 shares of Premier, Inc. stock.
Premier, Inc. Insider Trading Activity
Premier, Inc. insiders have traded $PINC stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $PINC stock by insiders over the last 6 months:
- MICHAEL J. ALKIRE (President & CEO) has traded it 8 times. They made 0 purchases and 8 sales, selling 98,133 shares.
- LEIGH ANDERSON (Chief Operating Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 60,000 shares.
- CRAIG S. MCKASSON (CAO & CFO) has traded it 3 times. They made 0 purchases and 3 sales, selling 50,000 shares.
- ANDY BRAILO (Chief Commercial Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 50,497 shares.
- DAVID L KLATSKY (General Counsel) has traded it 3 times. They made 0 purchases and 3 sales, selling 16,528 shares.
- JODY R DAVIDS sold 13,600 shares.
- HELEN M BOUDREAU sold 6,629 shares.
To track insider transactions, check out our insider trading dashboard.
Premier, Inc. Hedge Fund Activity
We have seen 117 institutional investors add shares of Premier, Inc. stock to their portfolio, and 150 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. added 5,007,851 shares (+384.3%) to their portfolio in Q2 2024
- BANK OF AMERICA CORP /DE/ added 3,062,901 shares (+255.4%) to their portfolio in Q2 2024
- BLACKROCK INC. removed 2,271,188 shares (-13.8%) from their portfolio in Q2 2024
- VANGUARD GROUP INC removed 1,620,010 shares (-11.7%) from their portfolio in Q2 2024
- GOLDMAN SACHS GROUP INC removed 1,096,782 shares (-76.2%) from their portfolio in Q2 2024
- FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ removed 1,012,994 shares (-100.0%) from their portfolio in Q2 2024
- NORGES BANK removed 865,699 shares (-37.8%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out our institutional holdings dashboard.
Should I Buy $PINC Stock?
For Premier Inc. ($PINC), the bull case is underscored by robust growth in its Performance Services segment, which saw a 15% revenue increase to $108 million, coupled with an overall 3% rise in fourth-quarter revenue to $350 million and an impressive adjusted EBITDA of $119 million. The company's operational resilience is highlighted by a significant 14% increase in Supply Chain Services AEBITDA, suggesting strong performance across various segments despite potential challenges in GPO contract renegotiations. However, the bear case presents concerns about financial stability, as Supply Chain Services revenue declined by 4% to $211 million, and the company's FY24 revenue outlook was cut to $1.31 billion from $1.37 billion. A dramatic drop in free cash flow from $264 million to $116 million, mainly due to significant tax liabilities from divesting its non-healthcare GPO, alongside unfavorable trends in net admin fees and an anticipated 16% product revenue reduction, raises red flags about Premier's ability to sustain profitability in the near term.
Background on $PINC Stock
Premier, Inc. is a healthcare improvement company that partners with hospitals, health systems, and other healthcare providers to enhance operational efficiency, clinical outcomes, and cost-effectiveness. Founded in 2013, Premier offers a range of services, including group purchasing, data analytics, supply chain management, and performance improvement solutions. The organization leverages its extensive database and industry expertise to help members identify best practices, optimize resource management, and implement innovative strategies to navigate the complexities of the healthcare landscape. By facilitating collaboration and sharing insights, Premier aims to drive high-quality, patient-centered care while lowering healthcare costs across its network.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
